- Report
- May 2023
- 150 Pages
Global
From €3397EUR$3,850USD£2,974GBP
€4279EUR$4,850USD£3,747GBP
- Training
- October 2024
- 2 Days
Global
From €1409EUR$1,597USD£1,233GBP
- Training
- April 2024
- 90 Minutes
Global
From €441EUR$500USD£386GBP
- Training
- September 2025
- 3 Hours
Global
From €792EUR$898USD£693GBP
- Training
- August 2025
- 3 Hours
Global
From €792EUR$898USD£693GBP
- Webinar
- February 2024
- 120 Minutes
Global
From €432EUR$490USD£378GBP
- Training
- 90 Minutes
Global
- Training
- March 2026
- 2 Days
Russia
€1535EUR$1,801USD£1,299GBP
€1772EUR$2,079USD£1,499GBP
- Training
- November 2025
- 3 Hours
Global
From €792EUR$898USD£693GBP
- Report
- October 2025
- 90 Pages
Bahrain
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 93 Pages
Oman
From €4279EUR$4,850USD£3,747GBP
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 88 Pages
Philippines
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 91 Pages
Philippines
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 96 Pages
Saudi Arabia
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 83 Pages
Vietnam
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 86 Pages
Saudi Arabia
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 82 Pages
Saudi Arabia
From €4279EUR$4,850USD£3,747GBP
- Training
- October 2025
- 60 Minutes
Global
From €529EUR$600USD£464GBP
- Report
- October 2025
- 96 Pages
South Korea
From €4279EUR$4,850USD£3,747GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more